|
CBDMD, Inc. (YCBD) DCF -Bewertung
US | Healthcare | Drug Manufacturers - Specialty & Generic | AMEX
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
cbdMD, Inc. (YCBD) Bundle
Suchen Sie, um den inneren Wert von CBDMD, Inc. zu bewerten? Unser (YCBD) DCF-Taschenrechner integriert reale Daten mit umfassenden Anpassungsfunktionen, sodass Sie Projektionen anpassen und Ihre Investitionsauswahl verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.9 | 44.5 | 35.4 | 24.2 | 19.5 | 16.3 | 13.6 | 11.4 | 9.5 | 8.0 |
| Revenue Growth, % | 0 | 6.2 | -20.41 | -31.77 | -19.35 | -16.33 | -16.33 | -16.33 | -16.33 | -16.33 |
| EBITDA | -16.9 | -22.0 | -15.5 | -7.5 | -1.5 | -5.6 | -4.7 | -3.9 | -3.3 | -2.7 |
| EBITDA, % | -40.26 | -49.48 | -43.72 | -30.92 | -7.67 | -34.41 | -34.41 | -34.41 | -34.41 | -34.41 |
| Depreciation | 1.9 | 2.3 | 3.0 | 2.9 | 1.8 | 1.3 | 1.1 | .9 | .8 | .6 |
| Depreciation, % | 4.54 | 5.07 | 8.39 | 12.12 | 9.34 | 7.89 | 7.89 | 7.89 | 7.89 | 7.89 |
| EBIT | -18.8 | -24.3 | -18.4 | -10.4 | -3.3 | -6.9 | -5.8 | -4.8 | -4.0 | -3.4 |
| EBIT, % | -44.8 | -54.54 | -52.11 | -43.04 | -17.02 | -42.3 | -42.3 | -42.3 | -42.3 | -42.3 |
| Total Cash | 15.1 | 27.4 | 7.7 | 1.8 | 2.5 | 4.6 | 3.8 | 3.2 | 2.7 | 2.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .9 | 1.1 | 1.4 | 1.2 | 1.0 | .6 | .5 | .4 | .4 | .3 |
| Account Receivables, % | 2.18 | 2.5 | 4.09 | 5.03 | 5.05 | 3.77 | 3.77 | 3.77 | 3.77 | 3.77 |
| Inventories | 4.6 | 5.0 | 4.3 | 4.1 | 2.4 | 2.1 | 1.7 | 1.4 | 1.2 | 1.0 |
| Inventories, % | 10.99 | 11.29 | 12.02 | 16.78 | 12.14 | 12.64 | 12.64 | 12.64 | 12.64 | 12.64 |
| Accounts Payable | 2.9 | 3.0 | 2.0 | 1.9 | 1.5 | 1.1 | 1.0 | .8 | .7 | .6 |
| Accounts Payable, % | 6.81 | 6.7 | 5.75 | 7.89 | 7.91 | 7.01 | 7.01 | 7.01 | 7.01 | 7.01 |
| Capital Expenditure | -1.3 | -2.3 | -.7 | -.3 | -.3 | -.4 | -.4 | -.3 | -.2 | -.2 |
| Capital Expenditure, % | -3.15 | -5.27 | -1.95 | -1.23 | -1.49 | -2.62 | -2.62 | -2.62 | -2.62 | -2.62 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -20.9 | -23.4 | -19.5 | -10.4 | -3.3 | -6.8 | -5.7 | -4.8 | -4.0 | -3.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -23.0 | -23.9 | -17.7 | -7.5 | -.2 | -5.7 | -4.8 | -4.0 | -3.3 | -2.8 |
| WACC, % | 9.58 | 9.52 | 9.58 | 9.58 | 9.58 | 9.57 | 9.57 | 9.57 | 9.57 | 9.57 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -16.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -3 | |||||||||
| Terminal Value | -38 | |||||||||
| Present Terminal Value | -24 | |||||||||
| Enterprise Value | -40 | |||||||||
| Net Debt | -1 | |||||||||
| Equity Value | -39 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | -9.01 |
What You Will Receive
- Comprehensive Financial Model: cbdMD’s actual data facilitates accurate DCF valuation.
- Complete Forecasting Control: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates allow you to view results instantly as you make adjustments.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Adaptable and Reusable: Designed for versatility, enabling repeated use for in-depth forecasts.
Key Features
- Comprehensive YCBD Data: Pre-filled with cbdMD's historical performance metrics and future growth forecasts.
- Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Testing: Develop various forecasting scenarios to assess different valuation results.
- User-Friendly Design: Intuitive, organized layout suitable for both professionals and novices.
How It Works
- Step 1: Download the Excel file for cbdMD, Inc. (YCBD).
- Step 2: Examine cbdMD’s pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
- Step 5: Evaluate the outputs and leverage the findings for investment choices.
Why Choose This Calculator for cbdMD, Inc. (YCBD)?
- Accurate Data: Current cbdMD financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Built-in calculations save you from starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the CBD industry.
- User-Friendly: Simple design and clear instructions ensure accessibility for all users.
Who Should Use cbdMD, Inc. (YCBD)?
- Health Enthusiasts: Discover the benefits of CBD products and how they can enhance wellness.
- Researchers: Utilize data and insights for studies related to CBD and its effects.
- Consumers: Evaluate product options to find the best CBD solutions for personal needs.
- Retailers: Access a reliable source of high-quality CBD products to offer in your store.
- Investors: Analyze market trends and performance metrics to make informed decisions regarding cbdMD, Inc. (YCBD).
What the Template Contains
- Pre-Filled Data: Includes cbdMD, Inc.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze cbdMD, Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.